These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 934517)
41. [Ophthalmological use of bencyclane and ophthalmodynamometric recording of its effect on cerebral vessels]. Födö V Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1450+. PubMed ID: 5536669 [No Abstract] [Full Text] [Related]
42. [Effects of enflurane on cerebral oxygen consuption and blood flow]. Takasaki M; Watanabe H; Horma H; Takahashi N Masui; 1974 Sep; 23(9):806-11. PubMed ID: 4475133 [No Abstract] [Full Text] [Related]
43. [Effect of komplamin and nikoshpan on brain circulation and metabolism in the postischemic period]. Nagornaia GV; Gaevyĭ MD Farmakol Toksikol; 1988; 51(1):38-41. PubMed ID: 3360105 [TBL] [Abstract][Full Text] [Related]
45. [Critical observations on the pharmacotherapy of arterial circulation disorders of the extremities]. Linke H Dtsch Gesundheitsw; 1965 Aug; 20(33):1505-16. PubMed ID: 5323383 [No Abstract] [Full Text] [Related]
46. [Isothiobarbamine prevention of disorders of carbohydrate and oxygen metabolism and of the development of brain edema in the early period after an intracerebral hemorrhage]. Plotnikov MB; Plotnikova TM; Iakimova TV; Saratikov AS Biull Eksp Biol Med; 1988 Dec; 106(12):688-90. PubMed ID: 3207876 [TBL] [Abstract][Full Text] [Related]
47. [Effect of the phencyclidine derivative ketamine (CI-581) on blood circulation and oxygen cnsumption of the dog brain]. Kreuscher H; Grote J Anaesthesist; 1967 Oct; 16(10):304-8. PubMed ID: 4872929 [No Abstract] [Full Text] [Related]
48. [Critical observations on vasodilator agents in peripheral vascular diseases and cerebrovascular disorders]. Hamming JJ; van der Drift JH Ned Tijdschr Geneeskd; 1968 Mar; 112(13):611-4. PubMed ID: 5664995 [No Abstract] [Full Text] [Related]
49. Effect of cytochrome C on the cerebral blood flow and metabolism. Lee TK; Yu H; Wang YH; Chen YH; Liaw H Taiwan Yi Xue Hui Za Zhi; 1975 Mar; 74(3):185-90. PubMed ID: 167100 [No Abstract] [Full Text] [Related]
50. Effects of 3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine on cerebral circulation and metabolism in cats. Izumi Y; Gotoh F; Fukuuchi Y; Hata T; Imai A; Isozumi K Arzneimittelforschung; 1990 Dec; 40(12):1300-3. PubMed ID: 2128864 [TBL] [Abstract][Full Text] [Related]
51. [Agents to improve cerebrovascular circulation and cerebral metabolism--general concepts and classification of the drugs]. Hirai S Nihon Rinsho; 1985 Feb; 43(2):361-4. PubMed ID: 2860262 [No Abstract] [Full Text] [Related]
52. [Effect of blood constituents on brain function during perfusion experiments with the cat brain. I. Brain perfusion with artificial blood containing low molecular weight dextran]. Morimitsu J Seishin Shinkeigaku Zasshi; 1968 Apr; 70(4):330-40. PubMed ID: 5693993 [No Abstract] [Full Text] [Related]
53. [The effects of cerebral vasodilators and stimulators of brain metabolism on the patients with vascular dementia]. Araki G Nihon Ronen Igakkai Zasshi; 1988 Jul; 25(4):390-5. PubMed ID: 3249441 [No Abstract] [Full Text] [Related]
54. Barbiturate loading following prolonged ischemia of the cat brain. Hossmann KA; Takagi S; Sakaki S Acta Neurol Scand Suppl; 1977; 64():376-7. PubMed ID: 268838 [No Abstract] [Full Text] [Related]
56. Cerebral circulatory and metabolism changes following amphetamine administration. McCulloch J; Harper AM Brain Res; 1977 Jan; 121(1):196-9. PubMed ID: 832157 [No Abstract] [Full Text] [Related]
57. Angiodyskinesia. A new vascular syndrome. Amir-Jahed AK Vasc Surg; 1968 Sep; 2(3):164-73. PubMed ID: 5759501 [No Abstract] [Full Text] [Related]
58. [Complementary facts relative to the pharmacology of vasodilating substances and to hemodynamic consequences of their general administration in the treatment of obliterative arterial diseases of the lower limbs]. Lambert J Rev Med Liege; 1967 Dec; 22(23):688-95. PubMed ID: 5590216 [No Abstract] [Full Text] [Related]
59. [Change of catecholamine level in the urine after the administration of vasodilating agents with chemical formulae related to adrenaline]. Yamamoto T Nihon Geka Hokan; 1968 Jul; 37(4):567-70. PubMed ID: 5750048 [No Abstract] [Full Text] [Related]
60. Intra-arterial fluorescein in the evaluation of a vasodilator drug. Harner RC; Rhame DW; Thoroughman JC South Med J; 1969 Apr; 62(4):424 passim. PubMed ID: 4388447 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]